151 related articles for article (PubMed ID: 37628666)
1. Characterization of the Effects of Host p53 and Fos on Gallid Alpha Herpesvirus 1 Replication.
Liu Z; Cui L; Li X; Xu L; Zhang Y; Han Z; Liu S; Li H
Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628666
[TBL] [Abstract][Full Text] [Related]
2. Fos Facilitates Gallid Alpha-Herpesvirus 1 Infection by Transcriptional Control of Host Metabolic Genes and Viral Immediate Early Gene.
Wang Z; Qiao Y; Chen Z; Liang Y; Cui L; Zhang Y; Li X; Xu L; Wei P; Liu S; Li H
Viruses; 2021 Jun; 13(6):. PubMed ID: 34207926
[TBL] [Abstract][Full Text] [Related]
3. P53 maintains gallid alpha herpesvirus 1 replication by direct regulation of nucleotide metabolism and ATP synthesis through its target genes.
Xu L; Chen Z; Zhang Y; Cui L; Liu Z; Li X; Liu S; Li H
Front Microbiol; 2022; 13():1044141. PubMed ID: 36504811
[TBL] [Abstract][Full Text] [Related]
4. PFT-α inhibits gallid alpha herpesvirus 1 replication by repressing host nucleotide metabolism and ATP synthesis.
Xu L; Wang Z; Chen Z; Cui L; Liu Z; Liang Y; Li X; Zhang Y; Liu S; Li H
Vet Microbiol; 2022 Jun; 269():109435. PubMed ID: 35462119
[TBL] [Abstract][Full Text] [Related]
5. Global exploration of the metabolic requirements of gallid alphaherpesvirus 1.
Qiao Y; Wang Z; Han Z; Shao Y; Ma Y; Liang Y; Chen Z; Wu H; Cui L; Zhang Y; Liu S; Li H
PLoS Pathog; 2020 Aug; 16(8):e1008815. PubMed ID: 32833996
[TBL] [Abstract][Full Text] [Related]
6. Genetic Diversity of Infectious Laryngotracheitis Virus during
Loncoman CA; Hartley CA; Coppo MJC; Vaz PK; Diaz-Méndez A; Browning GF; García M; Spatz S; Devlin JM
Appl Environ Microbiol; 2017 Dec; 83(23):. PubMed ID: 28939604
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Gene Expression Analysis Identifies the Proto-oncogene Tyrosine-Protein Kinase Src as a Crucial Virulence Determinant of Infectious Laryngotracheitis Virus in Chicken Cells.
Li H; Wang F; Han Z; Gao Q; Li H; Shao Y; Sun N; Liu S
J Virol; 2016 Jan; 90(1):9-21. PubMed ID: 26446601
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo characterization of glycoprotein C-deleted infectious laryngotracheitis virus.
Pavlova SP; Veits J; Blohm U; Maresch C; Mettenleiter TC; Fuchs W
J Gen Virol; 2010 Apr; 91(Pt 4):847-57. PubMed ID: 19940061
[TBL] [Abstract][Full Text] [Related]
9. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Beltrán G; Riblet S; Freitas CO; García M; Devlin JM
Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30242009
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein-C-gene-deleted recombinant infectious laryngotracheitis virus expressing a genotype VII Newcastle disease virus fusion protein protects against virulent infectious laryngotracheitis virus and Newcastle disease virus.
Wei X; Shao Y; Han Z; Sun J; Liu S
Vet Microbiol; 2020 Nov; 250():108835. PubMed ID: 33011664
[TBL] [Abstract][Full Text] [Related]
11. The UL47 gene of avian infectious laryngotracheitis virus is not essential for in vitro replication but is relevant for virulence in chickens.
Helferich D; Veits J; Teifke JP; Mettenleiter TC; Fuchs W
J Gen Virol; 2007 Mar; 88(Pt 3):732-742. PubMed ID: 17325345
[TBL] [Abstract][Full Text] [Related]
12. Infectious Laryngotracheitis Virus Viral Chemokine-Binding Protein Glycoprotein G Alters Transcription of Key Inflammatory Mediators
Coppo MJC; Devlin JM; Legione AR; Vaz PK; Lee SW; Quinteros JA; Gilkerson JR; Ficorilli N; Reading PC; Noormohammadi AH; Hartley CA
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070686
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide host responses against infectious laryngotracheitis virus vaccine infection in chicken embryo lung cells.
Lee J; Bottje WG; Kong BW
BMC Genomics; 2012 Apr; 13():143. PubMed ID: 22530940
[TBL] [Abstract][Full Text] [Related]
14. Replication-independent reduction in the number and diversity of recombinant progeny viruses in chickens vaccinated with an attenuated infectious laryngotracheitis vaccine.
Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Quinteros JA; Diaz-Méndez A; Thilakarathne D; Fakhri O; Vaz PK; Devlin JM
Vaccine; 2018 Sep; 36(38):5709-5716. PubMed ID: 30104116
[TBL] [Abstract][Full Text] [Related]
15. The Requirement of Glycoprotein C for Interindividual Spread Is Functionally Conserved within the Alphaherpesvirus Genus (
Vega-Rodriguez W; Ponnuraj N; Garcia M; Jarosinski KW
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452285
[TBL] [Abstract][Full Text] [Related]
16. Glycoprotein G (gG) production profile during infectious laryngotracheitis virus (ILTV) infection.
Bendezu J; Morales Ruiz S; Montesinos R; Choque Guevara R; Rojas-Neyra A; Pauyac-Antezana K; Fernández-Díaz M
PLoS One; 2019; 14(8):e0219475. PubMed ID: 31433806
[TBL] [Abstract][Full Text] [Related]
17. Propagation of infectious laryngotracheitis virus in an avian liver cell line.
Schnitzlein WM; Radzevicius J; Tripathy DN
Avian Dis; 1994; 38(2):211-7. PubMed ID: 7980266
[TBL] [Abstract][Full Text] [Related]
18. Host Src controls gallid alpha herpesvirus 1 intercellular spread in a cellular fatty acid metabolism-dependent manner.
Wang Z; Sun B; Gao Q; Ma Y; Liang Y; Chen Z; Wu H; Cui L; Shao Y; Wei P; Li H; Liu S
Virology; 2019 Nov; 537():1-13. PubMed ID: 31425969
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional analysis of membrane proteins gD, gE, gI, and pUS9 of Infectious laryngotracheitis virus.
Pavlova S; Veits J; Mettenleiter TC; Fuchs W
Avian Dis; 2013 Jun; 57(2 Suppl):416-26. PubMed ID: 23901755
[TBL] [Abstract][Full Text] [Related]
20. MAPK pathway orchestrates gallid alphaherpesvirus 1 infection through the biphasic activation of MEK/ERK and p38 MAPK signaling.
Cui L; Li X; Liu Z; Liu X; Zhu Y; Zhang Y; Han Z; Zhang Y; Liu S; Li H
Virology; 2024 Jun; 597():110159. PubMed ID: 38943781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
